Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: arguments for different mechanisms in the tumorigenesis
暂无分享,去创建一个
Leopoldo Sarli | C. Bordi | L. Sarli | L. Bottarelli | C. Azzoni | Cesare Bordi | Cinzia Azzoni | Lorena Bottarelli | Nicoletta Campanini | Gabriella Di Cola | Giovanni Bader | Antonio Mazzeo | Carlo Salvemini | Silvia Morari | Davide Di Mauro | Enrico Donadei | Luigi Roncoroni | L. Roncoroni | N. Campanini | C. Salvemini | D. Mauro | G. D. Cola | A. Mazzeo | Enrico Donadei | Giovanni Bader | Silvia Morari | G. Cola
[1] M. Kondo,et al. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. , 1995, Cancer research.
[2] L. Aaltonen,et al. Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. , 1993, Cancer research.
[3] H. Kawasaki,et al. Reduced Fhit expression is associated with mismatch repair deficiency in human advanced colorectal carcinoma , 2002, British Journal of Cancer.
[4] B. Leggett,et al. Prognostic significance of extensive microsatellite instability in sporadic clinicopathological stage C colorectal cancer , 2000, The British journal of surgery.
[5] L. D. Barnes,et al. Replacement of Fhit in cancer cells suppresses tumorigenicity. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[6] J. Masferrer,et al. COX‐2 is expressed in human pulmonary, colonic, and mammary tumors , 2000, Cancer.
[7] G. Lapertosa,et al. Primary mucinous adenocarcinomas and signet-ring cell carcinomas of colon and rectum. , 1994, Oncology.
[8] C. Bordi,et al. Abnormal Fhit protein expression and high frequency of microsatellite instability in sporadic colorectal cancer. , 2004, European journal of cancer.
[9] H. Weiss,et al. Prognostic Significance of p27kip-1 Expression in Colorectal Adenocarcinomas Is Associated with Tumor Stage , 2004, Clinical Cancer Research.
[10] M. Coleman,et al. Survival of cancer patients in europe—The EUROCARE study , 1995, Cancer Causes & Control.
[11] M. Tomonaga,et al. Alterations of the p27KIP1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma. , 1995, Blood.
[12] M. Loda,et al. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas , 1997, Nature Medicine.
[13] G. Capellá,et al. Prospective assessment of allelic losses at 4p14-16 in colorectal cancer: two mutational patterns and a locus associated with poorer survival. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[14] David Joseph,et al. Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer , 2000, The Lancet.
[15] H. Koeffler,et al. p27/Kip1 mutation found in breast cancer. , 1996, Cancer research.
[16] H. McLeod,et al. Tumour markers of prognosis in colorectal cancer , 1999, British Journal of Cancer.
[17] T. Pawlik,et al. Clinicopathologic features in colorectal cancer patients with microsatellite instability. , 2004, Mutation research.
[18] M. Beckmann,et al. Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer. , 1996, British Journal of Cancer.
[19] K. Nephew,et al. Epigenetic gene silencing in cancer initiation and progression. , 2003, Cancer letters.
[20] O. Dent,et al. Methodology and reporting in studies of local recurrence after curative excision of the rectum for cancer , 2001, The British journal of surgery.
[21] R. Gafà,et al. Chromosome 18q allelic loss and prognosis in stage II and III colon cancer , 1998, International journal of cancer.
[22] H. Zhang,et al. Loss of p27 expression predicts poor prognosis in patients with Dukes' B stage or proximal colorectal cancer. , 2001, International journal of oncology.
[23] D. Kerr,et al. The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] R. Gafà,et al. Sporadic colorectal adenocarcinomas with high‐frequency microsatellite instability , 2000, Cancer.
[25] I. Kirsch,et al. Prognostic significance of DNA replication errors in young patients with colorectal cancer. , 1998, Annals of surgery.
[26] American Joint Committee on Cancer Prognostic Factors Consensus Conference , 1999 .
[27] R. DuBois,et al. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 , 1995, Cell.
[28] A. Benhamiche,et al. Are there several colorectal cancers? Epidemiological data. , 1999, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[29] P. Quirke,et al. DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: a molecular study , 2002, The Lancet.
[30] P J Catalano,et al. Molecular predictors of survival after adjuvant chemotherapy for colon cancer. , 2001, The New England journal of medicine.
[31] H. Höfler,et al. Loss of heterozygosity and microsatellite instability in de novo versus ex-adenoma carcinomas of the colorectum. , 1998, The American journal of pathology.
[32] Detection of DCC and Ki‐ras gene alterations in colorectal carcinoma tissue as prognostic markers for liver metastatic recurrence , 1996, Cancer.
[33] T. Fleming,et al. Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] Emmanuel Mitry,et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. , 1990, The New England journal of medicine.
[35] J. Jass,et al. Emerging pathways in colorectal-cancer development. , 2002, The Lancet. Oncology.
[36] P. Holt,et al. Are right- and left-sided colon neoplasms distinct tumors? , 1997, Digestive diseases.
[37] T. Hla,et al. Overexpression of Cyclooxygenase-2 Is Sufficient to Induce Tumorigenesis in Transgenic Mice* , 2001, The Journal of Biological Chemistry.
[38] K. Sheahan,et al. The relationship between cyclooxygenase-2 expression and colorectal cancer. , 1999, JAMA.
[39] B. Iacopetta. Are there two sides to colorectal cancer? , 2002, International journal of cancer.
[40] L. Roncucci,et al. Evidence for the existence of different types of large bowel tumor: Suggestions from the clinical data of a population‐based registry , 1990, Journal of surgical oncology.
[41] Carolyn Compton,et al. American Joint Committee on Cancer prognostic factors consensus conference , 2000, Cancer.
[42] P. Vihko,et al. Loss of heterozygosity at 18q21 is indicative of recurrence and therefore poor prognosis in a subset of colorectal cancers , 1999, British Journal of Cancer.
[43] Z. F. Liu,et al. Allelic loss of chromosome 18q and prognosis in colorectal cancer. , 1994, The New England journal of medicine.
[44] A. Ristimäki,et al. Expression of cyclooxygenase-2 in human lung carcinoma. , 1998, Cancer research.
[45] J. Kleibeuker,et al. Change in Anatomic Distribution and Incidence of Colorectal Carcinoma Over a Period of 15 Years , 2002, Diseases of the colon and rectum.
[46] A. Lindblom. Different mechanisms in the tumorigenesis of proximal and distal colon cancers , 2001, Current opinion in oncology.
[47] K. Dohi,et al. Mucinous Carcinoma of the Colon and Rectum , 1994 .
[48] D. Schaid,et al. Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers. , 1999, Journal of the National Cancer Institute.
[49] R. Mariani-Costantini,et al. Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer. , 2005, Oncology reports.
[50] R. Rosell,et al. Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer. , 1998, Gastroenterology.
[51] J. Ray,et al. Mucinous carcinoma—Just another colon cancer? , 1993, Diseases of the colon and rectum.
[52] G. Baretton,et al. Microsatellite instability, loss of heterozygosity, and loss of hMLH1 and hMSH2 protein expression in endometrial carcinoma. , 2002, Human pathology.
[53] S N Thibodeau,et al. Microsatellite instability in cancer of the proximal colon. , 1993, Science.
[54] [Two colons--two cancers? Proximal or distal adenocarcinoma: arguments for a different carcinogenesis]. , 1995, Bulletin du cancer.
[55] J. Slingerland,et al. The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer. , 1999, Annual review of medicine.
[56] J. Cheville,et al. p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. , 1999, The American journal of pathology.
[57] D. Gómez,et al. Anatomical distribution of colorectal cancer over a 10 year period in a district general hospital: is there a true “rightward shift”? , 2004, Postgraduate Medical Journal.
[58] Y. Ikeda,et al. Possibility of different cancer development between the proximal and distal colon: comparison of the distribution between adenomatous polyps and cancer. , 1998, Hepato-gastroenterology.
[59] F. Piard,et al. Are there several types of colorectal carcinomas? Correlations with genetic data. , 1999, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[60] C. Bordi,et al. Association Between Recurrence of Sporadic Colorectal Cancer, High Level of Microsatellite Instability, and Loss of Heterozygosity at Chromosome 18q , 2004, Diseases of the colon and rectum.
[61] K. Shirouzu,et al. Biological features of sporadic colorectal carcinoma with high-frequency microsatellite instability: special reference to tumor proliferation and apoptosis , 2004, International Journal of Clinical Oncology.
[62] I. Tomlinson,et al. Microsatellite instability and the clinicopathological features of sporadic colorectal cancer , 2001, Gut.
[63] J. Bufill,et al. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. , 1990, Annals of internal medicine.
[64] James T. L. Mah,et al. Incidence and Survival of Mucinous Adenocarcinoma of the Colorectum: A Population-Based Study From an Asian Country , 2004, Diseases of the colon and rectum.
[65] B. Vogelstein,et al. A genetic model for colorectal tumorigenesis , 1990, Cell.
[66] P. Modrich,et al. Mechanisms and biological effects of mismatch repair. , 1991, Annual review of genetics.
[67] K. Kinzler,et al. Genetic instability in colorectal cancers , 1997, Nature.
[68] P. Fleshner,et al. Age and sex distribution of patients with colorectal cancer , 1989, Diseases of the colon and rectum.
[69] A. Sonnenberg,et al. Continued Rightward Shift of Colorectal Cancer , 2002, Diseases of the colon and rectum.
[70] P. Chen,et al. Clinicopathological study of colorectal mucinous carcinoma in Taiwan: A multivariate analysis , 1996, Journal of gastroenterology and hepatology.
[71] R. DuBois,et al. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[72] R. Lothe,et al. Genetic tumor markers with prognostic impact in Dukes' stages B and C colorectal cancer patients. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[73] N. Bundred,et al. COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ , 2004, British Journal of Cancer.
[74] R. Roetzheim,et al. Predictors of proximalvs. distal colorectal cancers , 2001, Diseases of the colon and rectum.
[75] T. Yeatman,et al. Cyclooxygenase-2 expression in right- and left-sided colon cancer: a rationale for optimization of cyclooxygenase-2 inhibitor therapy. , 2004, Clinical colorectal cancer.
[76] A. Chapelle,et al. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability , 1995, Nature Genetics.
[77] N. Tanigawa,et al. Prognostic Significance of p27kip1 Protein Expression and Spontaneous Apoptosis in Patients with Colorectal Adenocarcinomas , 2000, Oncology.
[78] E. Van Cutsem,et al. Molecular and genetic defects in colorectal tumorigenesis. , 2002, Best practice & research. Clinical gastroenterology.
[79] Darryl Shibata,et al. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis , 1993, Nature.
[80] D. Schaid,et al. Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. , 1998, Cancer research.
[81] R. DuBois,et al. Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells , 1998, Cell.
[82] P. Bunn,et al. Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study. , 1998, Cancer research.